Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design.
about
Prospects for vaccine prevention of meningococcal infectionOuter membrane vesicles as platform vaccine technologyCrystallographic analysis of Neisseria meningitidis PorB extracellular loops potentially implicated in TLR2 recognitionMeningococcal carriage and disease--population biology and evolutionAn OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and ToxicityMolecular epidemiology of Neisseria meningitidis serogroup B in BrazilCan Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease?Adjuvant efficacy of mOMV against avian influenza virus infection in mice.Emerging experience with meningococcal serogroup B protein vaccines.Recent Progress in the Prevention of Serogroup B Meningococcal Disease.AgdbNet - antigen sequence database software for bacterial typing.Meningococcal genetic variation mechanisms viewed through comparative analysis of serogroup C strain FAM18.Phasevarions mediate random switching of gene expression in pathogenic Neisseria.Phase variation mediates reductions in expression of surface proteins during persistent meningococcal carriage.Fitness estimates from experimental infections predict the long-term strain structure of a vector-borne pathogen in the field.Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.Clonal distribution of disease-associated and healthy carrier isolates of Neisseria meningitidis between 1983 and 2005 in CubaHuman T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved.Molecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines.Detecting genomic regions associated with a disease using variability functions and Adjusted Rand Index.Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing.Persistence of hyperinvasive meningococcal strain types during global spread as recorded in the PubMLST database.Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989.The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: potential implications of emergence of new strains.Phenotypic and genotypic characteristics of Neisseria meningitidis disease-causing strains in Argentina, 2010.Molecular targets in meningococci: efficient routine characterization and optimal outbreak investigation in conjunction with routine surveillance of the meningococcal group B vaccine candidate, fHBPVariation and molecular evolution of HmbR, the Neisseria meningitidis haemoglobin receptorImproved production process for native outer membrane vesicle vaccine against Neisseria meningitidis.Molecular characterization of invasive Neisseria meningitidis strains isolated in Chile during 2010-2011Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidis.Single nucleotide polymorphism in Ag85 genes of Mycobacterium tuberculosis complex: analysis of 178 clinical isolates from China and 13 BCG strains.Genome sequencing and analysis of BCG vaccine strains.Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementationRole of stochastic processes in maintaining discrete strain structure in antigenically diverse pathogen populations.Potential of recombinant opa proteins as vaccine candidates against hyperinvasive meningococci.A gene-by-gene population genomics platform: de novo assembly, annotation and genealogical analysis of 108 representative Neisseria meningitidis genomesIS1301 fingerprint analysis of Neisseria meningitidis strains belonging to the ET-15 clone.Refolding, purification and crystallization of the FrpB outer membrane iron transporter from Neisseria meningitidisDeletion of fetA gene sequences in serogroup B and C Neisseria meningitidis isolatesFetA Antibodies Induced by an Outer Membrane Vesicle Vaccine Derived from a Serogroup B Meningococcal Isolate with Constitutive FetA Expression.
P2860
Q24537338-F9509A02-F7F0-4923-BB4C-BD1909801B1CQ26766539-7F5FDCFB-E0E2-44AA-8310-2F44FC4F7351Q27681022-AD4B37D9-EEAE-4CAA-811E-1C557E6E030BQ28246008-FA4A0196-9E33-458F-9D50-65F790D4FC9EQ28607442-B0423B93-A652-45F2-830D-EC5DB62DBAE5Q28731309-46936D32-CA4D-40B0-A56C-D19352BAD008Q30150784-8C29104D-6FD3-4DB7-9E78-4814CEA70AF8Q30219688-3CAF91B1-8F4E-45A8-98CC-28BBA349CEF0Q30234958-D45B1378-66DC-4648-96E7-7BF7934AE54CQ30235040-408195C2-F748-4514-BB3D-F7A5B4B2C4D1Q33247489-F3164091-8C2F-4003-BEF1-4A1E3A3CA734Q33274203-47A799A5-BB85-458C-83F2-5286DDADEDC2Q33434451-519AD3CF-4F01-41FE-BE16-44DAF2E6F8B8Q33603065-008AAAB1-2A8E-48DE-8112-649EB7824AE3Q33686914-BD067159-8B00-4911-A288-470DBAEBC7FEQ33703560-C8075993-3508-4956-93BF-E19AA0738639Q33704817-F963562B-4C88-4B45-B0F3-E5802BDBC873Q33906285-77647822-38AE-4BEB-BCAD-81F2DBBA1ED6Q33913048-79A88B43-B9DC-4925-BB78-CCF5607653BBQ34094091-91DC1767-4EC1-40D3-9F5A-183E8AA9B5E9Q34108549-12935B69-6CF2-43DB-834C-FE00D24D0900Q34428829-1F5099AD-B87B-4B35-9203-88BEDB0F5250Q34431744-3743361C-34B6-4148-BD2F-D7B03FAB9706Q34500581-19C6BBA7-009F-4EFF-BA74-D9BF87CAE57AQ34618580-211993AA-C3DB-41A8-845A-EBC4BB84F498Q34738737-3887B4BA-36E5-4334-8C18-F5020D9FB4BCQ34746786-16E02A2B-1BB2-4A5B-B28B-2CE9EC568BD7Q34761285-86A80BF7-6C3C-4AC7-8EB0-BBF391FE1799Q34776133-A21AA192-4F15-42B6-BFC7-C5527B8BE16EQ34836342-13C1392D-A1C2-409A-9281-20A200F036B1Q34942828-926C6666-19E0-4895-98B4-E79DE36F1CD0Q34970721-FECE32AD-97AD-4D79-9D1D-A7AE2CC7FF0EQ35188450-A65E21D8-3A2F-464B-BAB6-3E157FD5D469Q35216888-6B17FE0E-7265-45BB-B219-FB700C07E367Q35328649-19BF15E3-C304-472F-8EBD-B82AC2861B6AQ35530102-7ED5AD23-ECE6-47E3-96BD-D936298C404EQ35690291-A8245892-F855-4AEC-9DD7-B569BF59F018Q35742066-7C61DE03-E15C-4A67-9411-4E9BCA8C9A5BQ35784238-F177DEB7-7767-4CC4-B2C5-18914C32B6BEQ35806559-195A4FD2-1D1D-41D9-9688-08898742B9D9
P2860
Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Distribution of surface protei ...... plications for vaccine design.
@en
Distribution of surface protei ...... plications for vaccine design.
@nl
type
label
Distribution of surface protei ...... plications for vaccine design.
@en
Distribution of surface protei ...... plications for vaccine design.
@nl
prefLabel
Distribution of surface protei ...... plications for vaccine design.
@en
Distribution of surface protei ...... plications for vaccine design.
@nl
P2093
P2860
P1476
Distribution of surface protei ...... mplications for vaccine design
@en
P2093
Emily A L Thompson
Ian M Feavers
Joanne E Russell
Rachel Urwin
P2860
P304
P356
10.1128/IAI.72.10.5955-5962.2004
P407
P577
2004-10-01T00:00:00Z